Cardiovascular effects of the R- and S-enantiomers of ibutilide in conscious beagle dogs

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 23, Issue 8, 2001, Pages 449-455

  Humphrey, S J ^a   Smith, M P ^a   Hsu, C Y L ^a   Walters, R R ^a  

^a PFIZER INC   (United States)

Author keywords

Antiarrhythmic; Cardiovascular; Dog; Enantiomer; Ibutilide

Indexed keywords

ANTIARRHYTHMIC AGENT; IBUTILIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOVASCULAR EFFECT; CONSCIOUSNESS; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ENANTIOMER; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; MEAN ARTERIAL PRESSURE; NONHUMAN; QT INTERVAL; RACEMIC MIXTURE;

EID: 0035687137     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2001.23.8.662135     Document Type: Article

References (36)

1. Electrophysiology and pharmacology of ibutilide
2. + current in guinea pig ventricular cells
3. Membrane activity of class III antiarrhythmic compounds: A comparison between ibutilide, d-sotalol, E-4031, sematilide, and dofetilide
4. + current through a nifedipine inhibited inward channel
5. The electrophysiological effects of U-70226E on isolated myocardium
6. N-[(omega-animo-l-hydroxyalkyl) phenyl] methanesulfonamide derivatives with class III antiarrhythmic activity
7. Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium
8. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-h canine myocardial infarction: A comparative study with sotalol and encainide
9. Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter
10. Acute intravenous conversion of canine atrial flutter: A comparison of antiarrhythmic agents
11. Antiarrhythmic and electrophysiological effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model
12. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
13. Efficacy of ibutilide for termination of atrial fibrillation and flutter
14. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function
15. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
16. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
17. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
18. Ibutilide: A new class III antiarrhythmic agent
19. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation
20. Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs
21. Ibutilide
22. Pharmacokinetics of ibutilide and its enantiomers in dogs
23. Whole body and regional hemodynamic effects of minoxidil in the conscious dog
24. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: Comparison to and cross tolerance with standard nitrovasodilators
25. Cardiovascular interactions characterizing the vasodilator components of nicorandil in conscious dogs
26. The heart rate-corrected QT interval of conscious beagle dogs: A formula based on analysis of covariance
27. Assay of the enantiomers of ibutilide and artilide using solid-phase extraction, derivation, and achiral-chiral column-switching high-performance liquid chromatography
28. Evaluation of the pharmacokinetics and pharmacodynamics of ibutilide fumarate and its enantiomers in healthy male volunteers
29. Comparison of pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogs
30. Stereoselective disposition of ibuprofen enantiomers in the dog
31. Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitor
32. Pharmacokinetics of the enantiomers of verapamil in the dog
33. Cardiovascular effects of YM-16151-1 and its optical isomers: A novel calcium entry blocking and β 1-adrenergic blocking agent
34. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs
35. Racemization and intramolecular nucleophilic substitution reactions of ibutilide